Evidence map›Paper›PMID 28525751›Full record

ReviewCell2017

Lamina-Associated Domains: Links with Chromosome Architecture, Heterochromatin, and Gene Repression.

Bas van Steensel, Andrew S Belmont

Open access · bronzeAbstract readReview
In one paragraph

Review in Cell, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 680 papers.

0numbers the graph read from it
0cells of the map it votes in
680citing papers in PubMed
45.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

680 citing papers in PubMed, 1,154 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. 3D Genome Engineering Using CRISPR/dCas Systems.International journal of molecular sciences · 2026
    Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

620 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Bas van SteenselDivision of Gene Regulation, Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands; Department of Cell Biology, Erasmus University Medical Center, 3015 CE Rotterdam, the Netherlands. Electronic address: b.v.steensel@nki.nl.
Andrew S BelmontDepartment of Cell and Developmental Biology, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA; Carl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA. Electronic address: asbel@illinois.edu.
Oncode Institute · NLUniversity of Illinois Urbana-Champaign · US

Funding

Mapping Technology DevelopmentU54DK107965 · NIDDK · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI BELMONT, ANDREW STEVEN · 2015 to 2019
$8.6M
CHROMATIN DOMAIN STRUCTURE/FUNCTIONR01GM058460 · NIGMS · UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN · PI BELMONT, ANDREW STEVEN · 1999 to 2025
$8.0M
NIDDK NIH HHS U54 DK107965NIGMS NIH HHS R01 GM058460
6 · The paper itself

Abstract

In metazoan cell nuclei, hundreds of large chromatin domains are in close contact with the nuclear lamina. Such lamina-associated domains (LADs) are thought to help organize chromosomes inside the nucleus and have been associated with gene repression. Here, we discuss the properties of LADs, the molecular mechanisms that determine their association with the nuclear lamina, their dynamic links with other nuclear compartments, and their proposed roles in gene regulation.

Indexed as

AnimalsCell NucleusChromatinGene Expression RegulationHeterochromatinHumansLaminsNuclear LaminaNuclear PoreChromatinHeterochromatinLaminschromosome architecturegene repressionheterochromatinLADslamina-associated domainsnuclear architecture

Identifiers

PMID28525751
PMCPMC5532494
OpenAlexW2616198309

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.